To the articles

USP Reference Standards – Standards of the United States Pharmacopeia
USP reference standards are the global quality benchmark for the analytical validation of pharmaceuticals, biologics, and excipients. Manufacturers of APIs, generics, complex biologics, or pharmaceutical raw materials require comparator substances that regulatory authorities and international pharmacopoeias fully trust.
As an authorized USP specialist retailer, we exclusively deliver standards – with the highest product safety, reliable supply chains and valid results for maximum patient safety.
The range of USP reference standards
Our portfolio includes thousands of USP standards , including:
✔ Drug active ingredient standards (APIs)
✔ Excipient standards
✔ Impurities & Degradation Products
✔ Nitrosamine standards
✔ Pharmaceutical Analytical Impurities (PAI)
✔ Analytical Reference Materials (ARM)
✔ Biologics Standards
✔ Compendial reagents
✔ Dissolution Performance Verification Standards (DPVS)
USP Pharmaceutical Analytical Impurities
READ MOREUSP Biologics
READ MOREUSP Analytical Reference Materials
READ MORE| Order no. | Article name | Batch number | CAS Number | Unit Price € | Quantity |
|---|---|---|---|---|---|
|
USP-1604202
Sale price999,02 €
|
Rifampin Quinone (25 mg) (1,4-dideoxy-1,4-dihydro-3-[[[4-methyl-1-piperazinyl]imino]methyl]-1,4-dioxo-rifamycin) |
R109W0 | 13983-13-6 | 999,02 € | |
|
USP-1604348
Sale price979,16 €
|
Riluzole Related Compound A (25 mg) (4-(Trifluoromethoxy)aniline) |
F1I207 | 461-82-5 | 979,16 € | |
|
USP-1604494
Sale price1.053,94 €
|
Riociguat System Suitability Mixture II (25 mg) (This is a mixture containing riociguat, riociguat related compound A and riociguat related compound C) |
F140E0 | N/A | 1.053,94 € | |
|
USP-1604527
Sale price1.139,23 €
|
Riociguat System Suitability Mixture (25 mg) (This is a mixture containing (approximately 0.2% of related compound B and 0.5% of related compound C) riociguat, riociguat related compound B and riociguat related compound C) |
F140D0 | N/A | 1.139,23 € | |
|
USP-1604541
Sale price969,81 €
|
Rivaroxaban R-enantiomer (20 mg) ((R)-5-Chloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide) |
R16940 | 865479-71-6 | 969,81 € | |
|
USP-1604552
Sale price1.426,67 €
|
Rivaroxaban Related Compound B (20 mg) ((S)-N-({2-Oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)acetamide) |
R197L0 | 1429334-00-8 | 1.426,67 € | |
|
USP-1604563
Sale price1.358,90 €
|
Rivaroxaban Related Compound D (20 mg) (1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea) |
R197K0 | 1365267-35-1 | 1.358,90 € | |
|
USP-1604574
Sale price1.358,90 €
|
Rivaroxaban Related Compound J (20 mg) |
R16990 | 1632463-24-1 | 1.358,90 € | |
|
USP-1604585
Sale price1.426,67 €
|
Rivaroxaban Related Compound H (20 mg) ((S)-4,5-Dichloro-N-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)thiophene-2-carboxamide) |
R17080 | 1770812-37-7 | 1.426,67 € | |
|
USP-1604596
Sale price1.426,67 €
|
Rivaroxaban Related Compound G (20 mg) ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione) |
R16750 | 446292-08-6 | 1.426,67 € | |
|
USP-1604621
Sale price979,16 €
|
Risedronate Related Compound A (20 mg) ([1-Hydroxy-2-(2-pyridinyl)ethylidene]bis(phosphonic acid), monohydrate) |
R05260 | 1220806-40-5 | 979,16 € | |
|
USP-1604632
Sale price1.080,81 €
|
Risedronate Related Compound B (20 mg) ([3,6-Bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt) |
R21800 | 2922985-14-4 | 1.080,81 € | |
|
USP-1604643
Sale price979,16 €
|
Risedronate Related Compound C (20 mg) ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid)) |
R195M0 | 75755-10-1 | 979,16 € | |
|
USP-1604665
Sale price1.091,33 €
|
Risperidone System Suitability Mixture (10 mg) |
R069V0 | N/A | 1.091,33 € | |
|
USP-1604676
Sale price1.080,81 €
|
Risperidone Related Compounds Mixture (25 mg) |
R26470 | N/A | 1.080,81 € | |
